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Abstract
Bardet-Biedl syndrome, BBS, is a rare autosomal recessive disorder with clinical presentations including polydactyly,
retinopathy, hyperphagia, obesity, short stature, cognitive impairment, and developmental delays. Disruptions of BBS
proteins in a variety of organisms impair cilia formation and function and the multi-organ defects of BBS have been
attributed to deficiencies in various cilia-associated signaling pathways. In C. elegans, bbs genes are expressed exclusively in
the sixty ciliated sensory neurons of these animals and bbs mutants exhibit sensory defects as well as body size, feeding,
and metabolic abnormalities. Here we show that in contrast to many other cilia-defective mutants, C. elegans bbs mutants
exhibit increased release of dense-core vesicles and organism-wide phenotypes associated with enhanced activities of
insulin, neuropeptide, and biogenic amine signaling pathways. We show that the altered body size, feeding, and metabolic
abnormalities of bbs mutants can be corrected to wild-type levels by abrogating the enhanced secretion of dense-core
vesicles without concomitant correction of ciliary defects. These findings expand the role of BBS proteins to the regulation
of dense-core-vesicle exocytosis and suggest that some features of Bardet-Biedl Syndrome may be caused by excessive
neuroendocrine secretion.
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Introduction
Bardet-Biedl Syndrome is a rare, multigenic, pleiotropic
disorder characterized by defects in many tissues including the
eyes, kidneys, central nervous system, and reproductive organs [1].
The clinical presentations of BBS include broadly prevalent
disease conditions such as obesity and retinopathy. Mutations in at
least 14 genes cause BBS [1–3]. Of these, seven interact to form a
complex termed the BBSome [4]. The mammalian BBSome
associates with ciliary membranes and interacts with a guanine
nucleotide exchange factor (GEF) for Rab8, a Rab GTPase
implicated in cilia formation and function [4]. The BBSome is
thought to act as a coat protein for cilia-bound vesicles, promoting
the sorting and delivery of signaling molecules to the cilium [5–7].
Given that cilia are sensory organelles enriched in signaling
molecules, the molecular functions of the BBSome have led to the
current paradigm for understanding Bardet-Biedl Syndrome in
which defects in cilia formation and signaling have been advanced
as a unifying explanation for the wide range of phenotypes seen in
BBS patients [3,8–11]. In support of this notion, conditional
knockouts in components of intraflagellar transport, IFT, a multi-
protein machinery required for building the cilium, have been
shown to result in some of the phenotypes present in bbs-deficient
mice such as obesity and kidney disease [12–14].
In C. elegans, the seven BBSome components are conserved and
are exclusively expressed in the 60 sensory neurons of this animal
[8]. Various subsets of these neurons have been implicated in
sensation of environmental cues that affect animal growth,
metabolism, and feeding behavior [15–17]. Disruptions of the C.
elegans BBSome cause altered rates of IFT, defects in the structural
integrity of sensory cilia, and diminished behavioral responses to
various sensory cues [8,9,18,19]. Thus, in C. elegans as in mammals,
loss of BBSome components leads to phenotypes that are also seen
in IFT mutants. Consequently, the physiological abnormalities of
C. elegans bbs mutants have also been attributed to defects in cilia
formation and signaling [9,18].
Here we report that BBSome mutants display a dramatic
increase in the secretion of dense-core vesicle cargoes from ciliated
sensory neurons, while mutations in IFT components generally
result in reduced secretion, indicating that the consequences of bbs
deficiency cannot be fully explained by impaired intraflagellar
transport. We show that the enhanced secretion of bbs-deficient
animals depends on the evolutionarily conserved Rab27/rabphil-
lin/CAPS exocytosis machinery but not on Rab8, which
participates in vesicular transport to the cilium. Importantly, we
show that the altered size, feeding, and metabolic phenotypes of
bbs mutants can be normalized to wild-type levels by abrogating
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the enhanced secretion of these mutants without simultaneous
correction of ciliary defects. We also demonstrate that while
certain phenotypes of IFT mutants mimic those caused by bbs
mutations, distinct neural and molecular mechanisms underlie
these phenotypes. These findings expand the role of the BBSome
to the regulation of dense-core vesicle secretion and raise the
possibility that enhanced neuroendocrine secretions rather than
ciliary defects per se may be primarily responsible for some of the
clinical features of BBS patients.
Results
C. elegans BBSome Mutants Exhibit Increased Secretion
of Insulins and Neuropeptides
To survive and thrive in a dynamic environment, C. elegans, as in
other animals, must sense changes in environmental conditions
and respond through behavioral, physiological, and metabolic
adaptations. C. elegans accomplishes this in part by secreting a
diverse array of neuroendocrine hormones including insulin-like
peptides from their various ciliated sensory neurons [20]. We had
previously shown that insulin secretion from the ADL pair of
ciliated sensory neurons can be assessed by expressing a
fluorescently tagged insulin, DAF-28-mCherry, exclusively in this
pair of neurons, and measuring the accumulation of the secreted
insulins in coelomocytes, scavenger cells that non-specifically
endocytose pseudocoelomic fluid [21]. It is thought that
peptidergic secretions from neurons such as ADL, which are not
directly in contact with the pseudocoelom, gain access to this space
through the extracellular matrix and the ancillary pseudocoelom, a
fluid fill cavity that bathes many of the neurons in the head of the
worm. Eventual passage of secreted molecules from the ancillary
pseudocoelom to the pseudocoelom is thought to be mediated by
tight junctions. Coelomocytes within the pseudocoelom non-
specifically endocytose pseudocoelomic fluids, concentrating them
in endocytic vesicles; thus, the steady state level of circulating
signaling molecules secreted from ADL can be measured by
quantifying the amount of fluorescent insulins within the
coelomocytes [21–23].
To better understand the molecular mechanisms that link
environmental cues to secretion of insulin-like peptides, we
examined the effects of various defects in cilia formation and
function on insulin secretion from the ADL pair of sensory
neurons. We found that mutations in intraflagellar transport, IFT,
components such as osm-3, osm-5, che-2, or che-11 [24], which result
in defective cilia, cause a ,50% reduction in insulin secretion
(Figure 1A,B,E,F) consistent with the idea that appropriate cilia
function is required for detection of food-related cues and
subsequent coordination of metabolic and growth pathways
through insulin signaling. We were therefore surprised to find
that cilia-defective osm-12 mutants [18], the C. elegans homolog of
bbs-7, exhibit a dramatic 2–3-fold increased insulin accumulation
in coelomocytes (Figure 1A–D). Mutations in bbs-1, bbs-5, bbs-8,
and bbs-9, encoding other components of the BBSome, also caused
enhanced accumulation of the insulin reporter in coelomocytes
(Figure 1C,D), suggesting that the entire BBSome complex
regulates insulin release from ADL sensory neurons.
The increased secretion was not limited to ADL neurons, as bbs
mutants also exhibited increased secretion when the fluorescent
insulin reporter was expressed exclusively in the ASI pair of
sensory neurons (Figure 1E,F). Additionally, BBSome mutants
exhibited a ,2–3-fold elevated secretion of DAF-7, a neurally
expressed TGF-b ligand and FLP-21, an FRMF-amide neuro-
peptide expressed under the ADL specific, srh-220, promoter
(Figure 1G,H), indicating that BBSome mutants have elevated
release of various dense-core vesicle cargoes from multiple ciliated
sensory neurons.
To assess whether the enhanced accumulations of the
fluorescent reporters in coelomocytes indicate functional increases
in the release of insulins and neuropeptides, we assayed
phenotypes associated with hyperactive insulin and neuropeptide
signaling. Insulin and TGF-b signaling pathways regulate whether
C. elegans grow reproductively or enter a hibernating dauer stage
[25]. Reductions in either of these parallel pathways initiate dauer
entry, while favorable conditions promote dauer exit and
reproductive growth. Accordingly, overexpression of either ins-4
or daf-28, encoding distinct insulins, partially suppresses the
constitutive dauer formation phenotype of TGF-b mutants [22].
We found that mutations in either bbs-7 or bbs-9 partially
suppressed the dauer phenotypes of daf-7 or daf-1 mutants,
encoding the TGF-b ligand and its receptor, respectively, but not
that of mutants in daf-2, the insulin receptor (Figure 2A and
unpublished data). Consistent with the notion that the enhanced
secretion of bbs mutants mediates dauer suppression, loss of tom-1,
an inhibitor of the dense-core vesicle release [26], also partially
abrogated dauer formation of TGF-b mutants (Figure 2A). By
contrast, mutations in IFT components such as osm-5 and che-11
failed to alter dauer formation of TGF-b mutants [27]. Therefore,
BBSome mutants display enhanced insulin signaling and have the
same impact on dauer formation and maintenance as animals with
Author Summary
Bardet-Biedl syndrome, BBS, is a rare human genetic
disease caused by mutations in many genes. The BBS
phenotype is very complex; it is principally characterized
by early-onset obesity, progressive blindness, extra digits
on the hands and feet, and renal problems. BBS patients
may also suffer from developmental delay, learning
disabilities, diabetes, and loss of the sense of smell. This
complexity suggests that BBS proteins function in a variety
of tissues, causing defects in many organs. A unifying
theme for the diverse features of BBS emerged when BBS
genes were identified and their protein products were
found to function in the cilium, a sensory structure found
in many cell types. Since then, the various manifestations
of BBS have been attributed to the loss of ciliary function
in the corresponding tissues. This notion was also
supported by the finding that mutations in several genes
required for proper cilia formation and function reproduce
some of the features seen in BBS patients. Here, we have
further investigated the defects found in Caenorhabditis
elegans strains carrying mutations in BBS genes (bbs
mutants). We find that not only do they display sensory
deficits associated with loss of ciliary function, but they
also exhibit increased release of multiple peptide and
biogenic amine hormones contained in dense-core vesi-
cles of ciliated sensory neurons. Importantly, limiting this
excessive hormonal release without correcting the ciliary
defects of bbs mutants was sufficient to restore normal
body size, feeding, and metabolism to these mutants.
Moreover, we show that although non-bbs ciliary muta-
tions can mimic some of the phenotypes of bbs mutants,
these effects can be attributed to distinct spatial and
molecular mechanisms. Our findings indicate that C.
elegans bbs mutants exhibit features of both ciliary and
endocrine defects and suggest that some of the clinical
manifestations of human BBS may result from excessive
endocrine activity, independently of the loss of ciliary
function.
The BBSome Inhibits Dense-Core Vesicle Release
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enhanced dense-core vesicle secretion and as such are distinct
from other ciliary defective mutants.
To functionally assess neuropeptide signaling in bbs mutants, we
examined the NPR-1 signaling pathway. FLP-21 is one of two
FRMF-amide neuropeptides that activates NPR-1, a neuropep-
tide-Y-like receptor that regulates C. elegans oxygen sensation and
social feeding [28]. Overexpression of FLP-21 can partially
suppress the hypomorphic npr-1(215F) but not the null mutation
of npr-1 as the hypomorph can still bind to FLP-21, albeit with a
lower affinity [28]. We found that mutations in either bbs-7 or bbs-
9 also partially suppress the social feeding phenotype of npr-
1(215F) but not that of the null mutant, suggesting that BBSome
mutants, as our reporter assay indicated (Figure 1G,H), have
increased FLP-21 release (Figure 2B). The hypersecreting tom-1
mutants similarly strongly suppressed the hypomorphic allele of
npr-1 but only weakly suppressed the null allele (Figure 2B). These
findings indicated that the enhanced secretion of neuropeptides as
assessed by fluorescent reporters indeed correlate to functional
increases in neuropeptide signaling in BBSome-deficient animals.
BBSome Acts in Part Cell Autonomously to Regulate
Secretion
To determine if the effects of the BBSome on dense-core vesicle
secretion are cell-autonomous, we expressed wild-type bbs-1 cDNA
under the control of various sensory neuron promoters in bbs-
1(ok1111) mutants. This bbs-1 transgene was fully functional as
judged by its capacity to fully rescue the small body size, feeding,
and dye-filling defect of bbs-1 mutants (Table S1; unpublished
data). Expression of bbs-1 under its own promoter or that of ocr-2,
which drives expression in ADL in addition to a few other sensory
neurons (see Table S1 for expression pattern), abrogated the
enhanced secretion of bbs-1 mutant animals (Figure 3A,B). By
contrast, use of the tax-4 promoter to drive expression in numerous
sensory neurons excluding ADL had no effect on the secretion
phenotype of bbs-1 mutants (Figure 3A,B). Expression exclusively
in ADL neurons showed partial but highly significant reduction in
the enhanced insulin secretion of bbs-1 mutants, suggesting that the
BBSome regulates secretion at least partially cell autonomously
(Figure 3A,B). The partial suppression could be due to differences
in promoter strength or regulation of secretion from other sensory
neurons. Similar results were obtained when a functional bbs-7
cDNA was expressed in a bbs-7 mutant: two independently
generated transgenic lines showed partial but highly significant
reductions of the enhanced insulin secretion of bbs-7 mutants when
expressed exclusively in ADL (Figure 3C,D). Finally, use of a heat
shock inducible promoter to induce expression of wild-type bbs-7
in late fourth larval stage bbs-7 mutants when the developmental
programs for ciliated neurons have been completed led to a partial
but significant abrogation of enhanced secretion (Figure 3E,F).
Thus, the requirement of the BBSome for wild-type secretion is, in
part, cell autonomous and not a consequence of altered neural
development.
Increased Neuroendocrine Release of bbs Mutants
Depends on the Conserved Rab27/AEX-6 Exocytosis
Pathway
As the cilia and BBS proteins have been shown to regulate
transcription through the TCF/LEF1 transcription factor [29], we
investigated whether the observed enhanced secretions could be
secondary consequences of increased transcription in bbs mutants.
While expression of FLP-21-mCherry translational reporter fusion
using the ADL-specific srh-220 promoter resulted in increased
accumulation of the secreted FLP-21-mCherry in coelomocytes
(Figure 1H), expression levels of the Psrh-220::gfp transcriptional
reporter were similar in wild type and bbs-9 mutants (Figure
S3A,B). Furthermore, transcript levels in several bbs mutants, as
measured by semi-quantitative RT-PCR, did not show any
significant increase in transcription of srh-220, daf-28, flp-21, daf-
7, or several other neuropeptide genes endogenously expressed in
ADL and ASI neurons (Figure S3C). Thus, enhanced secretion
Figure 2. BBSome mutants exhibit increased insulin and neuropeptide signaling. (A) BBSome and tom-1 mutants partially suppress the
dauer arrest of TG-b receptor daf-1, but not the insulin receptor, daf-2 mutants. The percentage of dauers is shown along with standard error of the
mean (*** p,0.001 compare to daf-1 animals). (B) BBSome and tom-1 mutants partially suppress the hypomorphic (215F) allele but not the null allele
of the NPY-like receptor npr-1. Percentage of animals feeding in social groups is shown with standard error (*** p,0.001, * p,0.05; ns, not significant,
comparing double mutants with the corresponding npr-1 single mutant).
doi:10.1371/journal.pbio.1001219.g002
Figure 1. Loss of BBSome increases release of insulins and neuropeptides. (A, C, E, G) Representative images of tagged insulin (DAF-28) or
neuropeptide (DAF-7, FLP-21) accumulation in coelomocytes (coel.), and (B, D, F, H) corresponding quantitation with standard error (*** p,0.001,
** p,0.01 compared to wild type). In each case, indicated insulin or neuropeptides were tagged with mCherry, while Punc-122::GFP was used to mark
coelomocytes.
doi:10.1371/journal.pbio.1001219.g001
The BBSome Inhibits Dense-Core Vesicle Release
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Figure 3. BBSome regulate secretion partially cell autonomously. (A, C, E) Representative images of tagged insulin accumulation in
coelomocytes, and (B, D, F) corresponding quantitation with standard error (*** p,0.001, ** p,0.01; ns, not significant, comparing transgenic to non-
transgenic siblings). (A, B) Transgenic (+) and non-transgenic siblings (2) expressing bbs-1 cDNA under the indicated promoters. Expression patterns
of these promoters are listed in Table S1. Transgenic (+) and non-transgenic siblings (2) expressing bbs-7 cDNA exclusively in ADL using the srh-220
promoter (C, D) or the heat shock inducible, hsp-16.2, promoter (E, F).
doi:10.1371/journal.pbio.1001219.g003
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levels of insulin, TGF-b ligand, and neuropeptides and the
corresponding increase in their associated signaling pathways are
unlikely to be secondary consequences of enhanced transcription
of insulin and neuropeptide genes.
To better understand the enhanced secretions of bbs mutants,
we next investigated the requirements of various components of
the dense-core secretion machinery. Regulated release of dense-
core vesicles is triggered by Ca+2 entry leading to activation of
UNC-31/CAPS, which promotes vesicle fusion with the plasma
membrane [30]. We previously showed that UNC-31 is required
for insulin release from ADL [21]. Therefore, we investigated
whether enhanced secretion of dense-core vesicle contents seen in
bbs mutants was dependent on UNC-31. We found that secretion
levels of bbs-7; unc-31 double mutants were indistinguishable from
unc-31 mutant alone (Figure 4A,B), indicating that the BBSome is
a negative regulator of Ca+2 stimulated release of dense-core
vesicles and does not affect the constitutive basal release seen in
unc-31 mutants. UNC-31 acts in parallel to TOM-1, the C. elegans
tomosyn [26]. Tomosyns negatively regulate both dense-core and
synaptic vesicle fusions by binding to and inhibiting syntaxins, an
essential component of the vesicle fusion machinery [26]. As in bbs
mutants, tom-1 mutants exhibited increased secretion from ADL
(Figure 3A,B) and the tom-1 and bbs-7 secretion phenotypes were
additive (Figure 4A,B). The finding that loss of unc-31 fully
abrogated the hypersecretion of bbs mutants cannot distinguish
whether the BBSome regulates secretion through mechanisms that
directly modulate the unc-31 pathway from indirect mechanisms
that ultimately depend on UNC-31 mediated secretion. However,
since the hypersecretion of bbs mutants was fully abrogated by unc-
31 but additive with that of tom-1 mutants, these findings suggest
that UNC-31 and the BBSome act in a common release pathway
in parallel to TOM-1.
Dense-core vesicles are trafficked from their site of formation in
the Golgi to the plasma membrane by Rab GTPases and their
regulators. Rab GTPases are a highly conserved family of proteins
involved in various aspects of vesicle fusion and transport. Previous
studies have indicated that the BBSome regulates Rab8 localiza-
tion and activity in mammalian cells [4]. bbs and rab-8 mutants in
C. elegans show similar defects in cilia membrane morphology,
suggesting that the BBSome is also likely to regulate Rab8 activity
in C. elegans [31]. However, rab-8 mutants exhibited wild-type
levels of secretion from ADL and loss of rab-8 did not change the
hypersecretion phenotype of bbs-7 mutants (Figure 4C,D). This
suggests that the BBSome might regulate dense-core vesicle
secretion through different Rabs. Previous studies have suggested
that Rab3 and Rab27 regulate vesicular exocytosis by promoting
the movement and tethering of dense-core vesicles to the plasma
membrane [32,33]. We found that AEX-6, the C. elegans homolog
of Rab27, was essential for dense-core vesicle secretion from ADL
and that its loss abrogated the enhanced secretion of bbs mutants
(Figure 4E,F). By contrast, loss of rab-3, another GTPase
implicated in exocytosis, had no effect (Figure 4E,F). The
enhanced secretion of bbs mutants was also dependent on
rabphilin/RBF-1, an effector of RAB-27/AEX-6 (Figure 4G,H),
and AEX-3, a RabGEF previously shown to regulate RAB-27/
AEX-6 and RAB-3 (Figure 3C,D) [32]. Taken together, these data
are consistent with a model whereby the BBSome acts as a
negative regulator of AEX-6/RBF-1/UNC-31, the worm coun-
terpart of mammalian Rab27/rabphilin/CAPS exocytosis ma-
chinery. Given that the mammalian BBSome binds to Rabin8, a
RabGEF for Rab8, and regulates Rab8 activity [4], the BBSome
might regulate dense-core vesicle secretion by regulating the
activity of AEX-3, the RabGEF for AEX-6/Rab27.
To further investigate the effects of bbs deficiency on dense-core
vesicles, we examined subcellular localization of IDA-1-GFP, a
tyrosine phosphatase-like receptor involved in protein secretion
that has been used as a maker of dense-core vesicles [34]. The
overall expression levels of IDA-1-GFP was similar in wild type
and bbs mutants, and in both cases GFP puncta were clearly visible
along axons as well as dendrites terminating in cilia (Figure S5 and
unpublished data). While the IDA-1-GFP reporter is largely
excluded from the cilia of wild type animals, it was prominently
visible in those of bbs mutants (Figure S5). Presence of the marker
in cilia of bbs mutants could suggest either mis-sorting of proteins
normally localized to dense-core vesicles or the appearance of
intact dense-core vesicles, which are normally excluded from cilia,
within these structures.
One mechanism that has been proposed to ensure proper
segregation of cilia-localized membrane proteins from other
plasma membrane proteins is the proteinaceous structure at the
base of the cilia known as the transition zone [35]. The transition
zone is thought to provide a barrier that helps exclude non-ciliary
proteins from the cilia [35]. Mutations in components of the
transition zone underlie ciliopathies such as Merkel-Gruber
syndrome and nephronophthisis, which share some clinical
features such as renal abnormalities with Bardet-Biedl syndrome
[2]. Unlike bbs mutations, however, mutations in genes encoding
components of the transition zone, such as mksr-1 and mksr-2 did
not cause enhanced neuroendocrine secretion (Figure S2).
Hyperactive Neuroendocrine Signaling Does Not Cause
Cilia Defects in bbs Mutants
The finding that loss of BBSome components enhances
secretion of dense-core vesicles prompted us to examine the
relationship between hyperactive neuroendocrine signaling and
ciliary defects of bbs mutants. Since losses of various IFT
components result in reduced secretion, we first investigated the
requirement of functional cilia for the enhanced secretion of bbs
mutants. We found that mutations in each of che-2 and che-11,
which cause reduced secretion levels (Figure 1A,B), completely
abrogate the enhanced secretion phenotype of bbs mutants (Figure
S2). These findings further validate the notion that the excess
secretion phenotype of bbs-deficient animals is not simply a
consequence of defective cilia but rather that some level of normal
ciliary function is required in order for the secretion phenotype of
bbs mutants to be manifested.
We next investigated whether ciliary defects of bbs mutants were
dependent on hypersecretion of dense-core vesicles. To assess
structural integrity of cilia in various mutants, we used a dye-filling
assay. Subsets of C. elegans sensory neurons have their ciliated
endings located near the surface of the animals and are directly
exposed to the environment for chemosensation. Upon immersion
of whole animals in a fluorescent dye solution, these neurons
become visible as the dyes can enter these neurons through their
cilia (Figure S1) [36]. Since animals with defective cilia formation
such as the IFT mutants fail to dye fill (Figure S1B) [36], this assay
has been used to assess cilia integrity and proper opening of the
cilia to the external environment. As previously reported, we found
that BBSome mutants also failed to dye fill (Figure S1) [18,37,38].
Interestingly, while mutations in the Rab27/rabphilin/CAPS
exocytosis machinery abrogated the enhanced secretion of bbs
mutants, they did not restore structural integrity to cilia in these
animals as judged by the inability of the double mutants to dye fill
(Figure S1C,D). These findings suggested that the structural and
functional defects of cilia in bbs mutants are unlikely to be a
consequence of hypersecretion of dense-core vesicles.
The BBSome Inhibits Dense-Core Vesicle Release
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To determine if ciliary structural deficiencies that manifest as
dye-filling defects are a pre-requisite for hyperactive secretion, we
examined the hypersecretion tom-1 mutants and found that they
exhibited normal dye filling (Figure S1B). We also found that while
bbs-5 mutants display similarly enhanced levels of secretion as
other BBSome mutants (Figures 1C,D and 5A), they dye fill like
wild-type animals (Figure S1A). Additionally, bbs-5 mutants
displayed normal expression of the serotonin synthesis enzyme,
tph-1 (Figure S4C,D), whereas expression of this enzyme was
shown to be elevated in many cilia-defective mutants [39] (Figure
S4C,D), further suggesting the presence of functional cilia, in bbs-5
mutants.
Together these findings suggest that the enhanced secretion
phenotype of bbs mutants depends on retention of some level of
ciliary function and that ciliary structural defects are not a pre-
requisite for enhanced release of dense-core vesicles. In turn,
enhanced release of dense-core vesicles can be abrogated without
concomitant correction of ciliary structural abnormalities of bbs
mutants.
The Reduced Body Size of bbs Mutants Is Due to
Enhanced Secretion
As various organism-wide phenotypes are controlled by
neuroendocrine signals, we asked whether some of the phenotypes
seen in C. elegans bbs mutant might be due to enhanced
neuroendocrine signaling in these mutants. Human BBS patients
are short statured, bbs mutant mice are born small [13,14,40], and
bbs mutant C. elegans have a reduced body size (Figure 5),
suggesting that size regulation might be a conserved function of
the BBSome. We found that tom-1 mutants, similar to BBSome-
Figure 5. Hyperactive secretion causes small body size of bbs mutants. (A) Quantitation with standard error of body sizes of bbs mutants
compared to wild type (*** p,0.001). (B) Mutations that abrogate enhanced secretion (rbf-1, aex-6, unc-31) normalize while loss of tom-1 further
reduces the body size of bbs mutants (*** p,0.001, ** p,0.01; ns, not significant, comparing double mutants to the corresponding single mutant). (C)
Quantitation with standard error of bbs-1 mutants expressing bbs-1 cDNA under the indicated neuron-specific promoters. Expression patterns of
these promoters are listed in Table S1 (* p,0.05, ** p,0.01, *** p,0.001, comparing transgenic animals to non-transgenic siblings). (D) Rabphilin, rbf-
1, suppresses the body-size defect of bbs-7 but not of IFT mutants, che-2 and che-11 (*** p,0.001; ns, not significant, comparing double mutant to
bbs-7 or IFT single mutant).
doi:10.1371/journal.pbio.1001219.g005
Figure 4. Increased secretion of bbs mutants requires the Rab27/AEX-6 dense-core vesicle exocytosis machinery. (A, C, E, G)
Representative image of tagged insulin accumulation in coelomocytes, and (B, D, F, H) corresponding quantitation with standard error are shown
(*** p,0.001; ns, not significant, comparing double mutants with the corresponding single mutant) for various components of dense-core vesicle
transport and release.
doi:10.1371/journal.pbio.1001219.g004
The BBSome Inhibits Dense-Core Vesicle Release
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deficient animals, exhibited reduced adult body size (Figure 5B),
suggesting that hypersecretion without ciliary defects can cause
small body size. Considering that some IFT mutants also exhibit
small body sizes (Figure 5D) [41], we sought to distinguish whether
the small body size of bbs mutants could be attributed to either
hypersecretion or ciliary defects. To do so, we suppressed the
enhanced secretion of BBSome mutants with mutations in the
dense-core vesicle exocytosis pathway (Figure 5B). Loss of rbf-1,
which suppressed the enhanced dense-core vesicle release of bbs
mutants, fully restored normal body size to bbs-7 mutants
(Figure 5B,D). By contrast, rbf-1 mutation failed to change the
small body of IFT mutants, suggesting that IFT and bbs mutants
regulate size through different pathways (Figure 5D). Similarly,
loss of unc-31 and aex-6, but not that of rab-3, conferred nearly
wild-type body size to bbs-7 mutants (Figure 5B). Importantly, in
all of these cases normalizations of body sizes were achieved
without functional correction of ciliary defects, as the double
mutants remained dye-filling defective (Figure S1C,D, unpub-
lished data). Furthermore, tom-1 mutants that exhibited an additive
secretion phenotype with BBSome mutants caused a further
reduction in the size of bbs mutant (Figure 5B). Together, these
findings suggest that the small size of BBSome mutants is due to
enhanced secretion of dense-core vesicle cargoes and distinct from
IFT mutants.
In further support of the notion that distinct mechanisms
underlie the small sizes of BBSome and IFT mutants, we also
found that neurons that function in size regulation in bbs mutants
are distinct from the neurons that function in size regulation in
IFT mutants. Normal body size can be restored to che-2 IFT
mutants by expressing wild-type che-2 cDNA in a subset of ciliated
neurons using the tax-4 promoter [42]. By contrast, expression of
functional bbs cDNAs using a tax-4 promoter failed to alter the
small body size of bbs mutants (Figure 5C and Table S1). The
body-size phenotype of bbs mutants could, however, be reverted to
wild-type levels when bbs cDNAs were expressed using an ocr-2
promoter, which directs expression to a distinct subset of neurons
than those expressing tax-4. This result indicates the spatial
requirements of the IFT machinery and the BBSome can be
attributed to distinct, non-overlapping neurons in the regulation of
body size (Figure 5C, see Table S1 for expression pattern). Thus,
despite phenotypic similarities, the size phenotypes of BBSome
and IFT mutants are based on distinct cellular and molecular
mechanisms.
Enhanced Neuroendocrine Secretion Underlies Metabolic
Phenotypes of bbs Mutants
As in the case of small body size, we found that a metabolic
phenotype exhibited by bbs mutants is mimicked by the
hyperactive secretion mutant tom-1 but not by IFT mutants.
Specifically, bbs mutants were previously reported to exhibit
increased accumulation of Nile Red and bodipy-labeled fatty
acids, vital dyes used as proxies for assessment of metabolic state in
intact animals [17,38,43–45]. As in body size, tom-1 mutants
exhibited a Nile Red phenotype that was reminiscent of that seen
in BBSome mutants, while IFT mutants such as osm-5 and che-11
exhibited wild-type patterns of Nile Red staining (Figure 6A,C). As
in body size and release of dense-core vesicles, tom-1 and bbs-7
mutants exhibited additive Nile Red phenotype (Figure S4A,B).
Furthermore, mutations in the Rab27 exocytosis pathway, which
abrogated the enhanced secretion of bbs mutants, restored wild-
type levels of Nile Red staining to bbs-7 mutants (Figure 6B,D),
suggesting that enhanced secretion underlies the Nile Red
phenotype of bbs mutants.
Enhanced Serotonin Release Underlies the Feeding
Phenotypes of bbs Mutants
In mice, the obesity seen in the setting of bbs deficiency has been
attributed to hyperphagia [13]. C. elegans BBSome mutants
similarly showed an altered food intake behavior (Figure 7). Food
intake behavior in C. elegans is assessed by counting the pumping
rate of the pharynx, an organ for ingesting bacteria [16,46].
Pumping rate is modulated by the availability of food supplies,
food quality, and prior feeding experience of the animals [47].
Although under plentiful food conditions, wild type and bbs-
deficient C. elegans display similar pumping rate [38], we found that
bbs-deficient animals, unlike wild-type animals, continue to exhibit
rapid pharyngeal pumps even when food supplies are exhausted
(Figure 7). This rapid pumping rate is unlikely to be merely a
consequence of defective cilia as many other cilia-defective
mutants exhibit wild-type pumping rate in the presence or
absence of food (Figures 7E, S4C) [41]. As in the case of body
size and vital dye staining patterns, reducing secretion of dense-
core vesicles without concomitant correction of ciliary defects was
sufficient to restore wild-type rates of food intake in bbs mutants
(Figure 7A).
One molecular mechanism known to modulate pumping rate is
serotonin signaling [48]. In C. elegans as in mammals, serotonin
production is dependent on the tryptophan hydroxylase enzyme,
tph-1. This enzyme is expressed in only a few neurons, only one
pair of which, the ADF neurons, is ciliated [48]. To investigate
whether abnormal serotonin signaling may underlie the enhanced
pumping rate of food-deprived bbs mutants, we expressed
functional bbs-1 cDNA using a tph-1 promoter in bbs-1 mutants.
bbs-1 reconstitution was sufficient to fully restore wild-type
pumping rate to bbs-1 mutants (Figure 7B, Table S1). Similarly,
all other promoters used to reconstitute wild-type bbs-1 that
express in ADF neurons fully rescued the feeding phenotype,
whereas expression of bbs-1 using promoters that do not target
ADF failed to alter the enhanced pumping rate of bbs-1 mutants
(Figure 7B,C, see Table S1 for expression pattern). Similar results
were obtained when bbs-7 cDNA was expressed in the ADF
neurons of bbs-7 mutants (Table S1). Consistent with the rescue
data, loss of tph-1 fully abrogated the enhanced pumping rate of bbs
mutants (Figure 7D). These findings suggest that the elevated
pumping rate of BBSome mutants is due to excessive serotonin
signaling initiated from ADF neurons.
Since elevated expression of tph-1 in ADF neurons has been
reported in numerous cilia-defective mutants including bbs (Figure
S4C,D) [39], we sought to distinguish whether the excess serotonin
signaling of bbs-deficient animals could be attributed to excessive
production of serotonin or to increased release of this biogenic
amine through dense-core vesicles. Despite elevated tph-1
expression, cilia-defective mutants such as che-2, che-11 and osm-5
exhibited wild-type pumping rates in the presence or absence of
food (Figures 7E, S4C), suggesting that increased tph-1 expression
does not necessarily correlate with excessive serotonin signaling. In
contrast, the hypersecretion mutant tom-1 mimicked the bbs
mutant feeding phenotype in that tom-1 mutants exhibited elevated
pumping rate when removed from food (Figure 7E). Furthermore,
bbs-5 mutants, in which cilia are relatively normal as assessed by
dye filling (Figure S1A), exhibited wild-type level of tph-1
expression in ADF neurons yet displayed elevated pumping in
the absence of food (Figure S4C,D). Thus, the elevated pumping
rate of bbs mutants is likely due to excessive release of serotonin
rather than increased synthesis via elevated expression of tph-1.
Taken together, our data indicate that while some ciliary-
defective mutants display size, metabolic, and feeding phenotypes
that are reminiscent of those seen in the bbs mutants, the
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underlying molecular and cellular bases of these phenotypes are
likely to be distinct. In turn, mutations that cause enhanced
secretion of dense-core vesicles without gross structural defects of
cilia mimic several physiological phenotypes seen in bbs mutants.
Inactivation of BBSome Components Causes Increased
Insulin Secretion from Mammalian b-Cells
Increased levels of circulating leptin and insulin in bbs-deficient
mice and humans have been reported [1,11,14,49]. In the case of
insulin, the increase is generally assumed to be a secondary
consequence of obesity and insulin resistance. However, our data
raise the possibility that elevated levels of these circulating
hormones may be in part a consequence of enhanced dense-core
secretion rather than secondary outcomes of obesity. To further
support this possibility, we employed Min6 cells, a mouse
pancreatic b-cell line that is ciliated and expresses BBSome
components. Treatment of Min6 cells with siRNAs targeting each
of three distinct BBSome subunits, Bbs5, Bbs7 and Bbs9, resulted
in ,1.5–2-fold increase in secreted insulin compared to control
siRNA (Figure 7F). Importantly, since these experiments were
conducted in cell lines, the enhanced secretion could not be merely
attributed to a secondary consequence of organismal obesity.
Consistent with this interpretation, excess circulating level of leptin
is evident in bbs-deficient mice before the onset of weight gain [11].
Discussion
Although disruptions in either the IFT machinery or the
BBSome can lead to similar structural and functional defects, here
we show that they elicit opposite effects on dense-core vesicle
secretion. Specifically, defects in the BBSome cause elevated
secretions of dense-core vesicles, while IFT defects generally cause
reduced secretions. Our findings indicate that this excess secretion
is largely cell autonomous, is not a consequence of altered
development, and is dependent on the C. elegans counterpart of
Rab27/rabphillin/CAPS exocytosis machinery but distinct from
the Rab8/Rabin8 vesicular transport machinery that helps target
membranes and cargoes to the cilium [4]. Therefore, we propose
that the role of the BBSome complex in vesicular transport within
ciliated cells should be expanded from ciliary functions
[4,5,8,10,18,19] and melanosome movement [4,50] to also include
dense-core vesicle exocytosis.
The current paradigm for understanding the myriad manifes-
tations of bbs deficiency is largely framed in the context of
defective ciliary functions arising from a failure to properly sort
receptors and other signaling molecules to the cilia
[5,6,8,10,11,18,19]. As such, mutations in the IFT machinery
and the BBSome are thought to cause similar ciliary defects albeit
with different levels of severity. This view emerged, in part, by the
observations that mutations in IFT components result in
Figure 6. Enhanced secretion caused metabolic defect in bbsmutants. Representative images (A, C) and quantitation with standard error (B,
D) of Nile Red staining in the first pair of intestinal cells of bbs-7, IFT, and dense-core vesicle secretion mutants (*** p,0.001; ns, not significant,
compared to wild type in B or comparing double mutants to the corresponding single mutant in D).
doi:10.1371/journal.pbio.1001219.g006
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organism-wide phenotypes that resemble those of BBSome
deficiency [12]. Our findings here indicate that while bbs
deficient animals share some of the defects of IFT mutants, the
consequences of these mutations on dense-core vesicle secretion
and resultant phenotypes are dramatically different from one
another. More importantly, our findings challenge the view that
similar mechanisms underlie all of the phenotypic similarities
caused by BBSome and IFT mutants. For instance, while mutants
in both IFT and BBSome components share defects in body size,
proper body size regulation requires these components in distinct
subsets of sensory neurons. Moreover, the small body sizes of bbs
mutants could be reverted to wild type upon abrogation of
enhanced secretion of dense-core vesicles, while similar manip-
ulations had no effects on the small body sizes of IFT mutant.
Figure 7. Reduction of dense-core vesicle secretion corrects feeding abnormalities of bbsmutants and BBS siRNA enhanced insulin
secretion from b-cells. unc-31, secretion defective mutant (A) and tph-1 serotonin synthesis mutant (D) suppress the increased pumping rate of bbs
mutants when starved (*** p,.001; ns, not significant, compare to wild-type starved pumping rate). (B, C) The pumping rate of transgenic animals
expressing bbs-1 cDNA under the indicated neuron-specific promoters in bbs-1 mutants was determined. Expression patterns of these promoters are
listed in Table S1. Pumping rate was restored to wild-type level when bbs-1 cDNA was expressed in the sole serotonergic ciliated neuron, ADF
(*** p,.001; ns, not significant, compared to wild-type starved pumping rate). (E) bbs mutants shared increased pumping rate when starved with
hypersecretion tom-1 mutants in contrast to che-2, che-11, and osm-5 IFT mutants (*** p,.001; ns, not significant, compared to wild-type starved
pumping rate). (F) siRNA against BBSome subunits in Min6 cells increases release of insulin into the surrounding media relative to control siRNA
(* p,0.05, ** p,0.01, *** p,.001, compared to control siRNA).
doi:10.1371/journal.pbio.1001219.g007
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Similarly, it has been reported that BBSome and IFT mutants
displayed distinct phenotypes of a specific learning behavior in C.
elegans [51]; our findings suggested that this difference is likely to
reflect a role of dense-core vesicle release in this behavior. Finally,
consistent with the notion that some of the phenotypic
consequences of bbs deficiency are due to hypersecretion of
dense-core vesicles, we found that tom-1 mutants, which cause
hypersecretion without obvious ciliary defects, exhibit the size,
metabolic, and feeding abnormalities similar to bbs mutants.
We do not currently know the precise mechanisms through
which bbs deficiencies cause hypersecretion of dense-core vesicles.
Although the enhanced secretion phenotype of bbs mutants can
be manipulated independently of their ciliary defects, we found
that wild type IFT activity is required for manifestation of the
hypersecretion phenotype. These findings are consistent with
several models. In one model, bbs mutants may mislocalize or
excessively accumulate receptors that modulate dense-core vesicle
release within the cilia [9]. Given that cilia bound vesicles and
dense-core vesicles both arise at the trans-Golgi membrane, it is
possible that as a coat-protein, the BBSome not only sorts the
appropriate cilia-localized proteins but also prevents the inap-
propriate accumulation of other molecules in this organelle.
Consistent with this scenario, we found that accumulation of
IDA-1-GFP, a marker of dense-core vesicles normally excluded
from the cilia, accumulates in cilia of bbs mutants (Figure S5). An
alternative but not mutually exclusive possibility is that the
BBSome may regulate dense-core vesicle release as a separate
function from its role in sorting membranes and cargoes to the
cilium. Given that the BBSome regulates cilia-bound vesicles
through binding Rabin8 [4], it is possible that the BBSome
regulates the Rab27/rabphillin/CAPS exocytosis pathway
through binding specific regulatory components of this machinery
such as AEX-3, the RabGEF for RAB-27/AEX-6. The idea that
the transport machinery associated with cilia formation and
function may not be restricted to these organelles and may have
evolved from existing cellular machinery has been suggested by
the recent demonstration that IFT proteins also play a role in
polarized receptor trafficking to a cellular region reminiscent of
the cilia in non-ciliated cells [52]. Additionally, the BBSome
mediates the movement of melanosomes on microtubules tracks,
an organelle not directly associated with the cilia, suggesting that
the BBSome might have cilia-independent functions [50]. The
genetic epistasis studies presented here do not distinguish between
these possibilities. Whether the effects of bbs deficiency on dense-
core vesicle secretion are cilia-independent functions of the
BBSome or secondary consequences of ciliary abnormalities, our
findings challenge the existing paradigm that phenotypic
manifestations of the bbs deficiency are recapitulated by IFT
mutations. The most salient insight to emerge from our findings is
that several of the organismal phenotypes seen in bbs mutants are
shared with hypersecretion tom-1 mutants and can be reverted to
wild-type by abrogating the hypersecretion of these mutants
without concomitant correction of ciliary defects. Although a
number of defects seen in bbs patients are likely to be
consequences of mis-localized ciliary proteins, we believe that
the etiologies of some features of BBS merit re-evaluation in light
of the role of this complex in dense-core vesicle secretions. While
the specific hormonal pathways that underlie the behavioral and
physiological abnormalities of C. elegans may or may not play
similar roles in mammals, excessive hormonal secretions are likely
to contribute to disease manifestations in BBS patients. For
instance, obesity and hyperphagia of BBS patients may be a
direct consequence of or exacerbated by increased secretion of
appetite-promoting hormones, and hypertension in these patients
could be caused by increased release of catecholamines. The
finding that hypersecretion in bbs deficiency can be abrogated
without correcting concomitant ciliary defects may open the door
to new strategies for treating patients with Bardet-Biedl
syndrome.
Materials and Methods
Strain Constructions
Strains were constructed by standard C. elegans methods [53].
Strains obtained from the C. elegans Genetics Center or the
National Bioresourse Project were backcrossed at least 46 with
wild type before phenotypic assessment. Transgenic animals were
generated by injecting the plasmid of interest at 100 ng/ml with
20–50 ng/ml of Punc-122::GFP or Pmyo-3::GFP as co-injection
marker. Plasmids were construct by Gateway cloning as described
in [21].
Coelomocyte Insulin and Neuropeptide Uptake Assay
Coelomocyte uptake assays were performed as described in [21]
with the exception that 20–40 animals were imaged for each strain
at sub-saturating exposure with the shutter half open to split
fluorescence between the eyepiece and the camera.
Ptph-1::GFP and Psrh-220::GFP Measurements
,30 sychronized adults for Ptph-1::GFP and L4 of Psrh-220::GFP
expressing animals were imaged at 406magnification on a Zeiss
Axioplane microscope at a sub-saturating exposure. The neuron of
interest was circled and GFP fluorescent within that neuron
quantified with OpenLab software. The minimum fluorescence is
subtracted from the mean for each cell. The mean and standard
error of the mean was determined for each strain and and
normalized to wild type.
Heat Shock Induction
Synchronized mid L4 animals were heat shocked on plates at
37uC for an hour and allowed to recover at 20uC for 4 h before
phenotypic assessment.
Body Size Measurement
DIC images of 20–40 animals were taken at 56magnification
and the outline of each animal was traced by OpenLab software.
The mean and standard error of the perimeter was calculated for
each strain and normalized to wild type.
Dauer Assay
,200 synchronized L1 animals for each strain were plated onto
five plates and incubated at 25uC for 2 d before the percentage of
dauer animals was determined along with standard error of the
mean.
Social Feeding Assay
The assay was preformed as described in [28] on six plates per
strain. The percentage of animals feeding in groups was
determined along with standard error of the mean.
Dye-Fill Assay
,300 synchronized L4 worms were washed into 1.5 ml
eppendorf with S-basal and incubated with 1 ml of 10 mg/ml of
DiI in 1 ml of S-basal for ,2 h rotating at room temp. Worms
were than pelleted and washed once with S-basal and plated onto
an OP50 seeded plate for ,1.5 h before imaging at 166 on a
Zeiss Axioplan microscope.
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Pharyngeal Pumping Assay
Pumping rate was measured essentially as described in [16] with
the exception that pumping rates were determined in 10-s intervals
for 10 animals for each genotype. The average pumping rate and
standard error of the mean were determined and normalized to
wild type.
Nile Red Staining Assay
,200 synchronized L1 animals were plated onto a 6 cm plate
containing 0.05 mg/ml of Nile Red and incubated at 20uC for 3 d.
Gravid animals were imaged using a TRITC filter at 166
magnification at a sub-satrating exposure with the shutter half
open to split fluorescence between eyepiece and the camera on a
Zeiss Axioplan microscope. The first pair of intestinal cells was
traced using the DIC image in OpenLab and the mean Nile Red
fluorescent minus the background was determined for 10–20
animals for each genotype. The average fluorescent along with the
standard error of the mean was determined for each strain and
normalized to wild type.
siRNA and Insulin Release in Min6 Cells
Min6 cells were treated with siRNAs from Qiagen with
Hiperfect (Qiagen) for 4 d in triplicates. Cells were rested in
Krebs-Ringer bicarbonate buffer for 2 h and then allowed to
release insulin into the media for an hour. Insulin was measured by
an ELISA kit (Mercodia) in duplicates and normalized to the total
insulin obtained after cell lysis. The mean and standard error was
calculated and expressed as a percentage of the control siRNA.
Semi-Quantitative RT-PCR
,10,000 synchronized L1 for each genotype were grown to L4
at 20uC. RNA extraction, cDNA prepartion, and RT-PCR were
preformed as described in [54] with primers and syber green PCR
mix from Qiagen. The data were standardized to the actin gene,
act-1. Data from two independent growths were aggragated for
statistical analysis.
Statistical Analyses
All statistical analyses were performed using a two-tailed student
t test.
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